JP2022509258A5 - - Google Patents
Info
- Publication number
- JP2022509258A5 JP2022509258A5 JP2021530885A JP2021530885A JP2022509258A5 JP 2022509258 A5 JP2022509258 A5 JP 2022509258A5 JP 2021530885 A JP2021530885 A JP 2021530885A JP 2021530885 A JP2021530885 A JP 2021530885A JP 2022509258 A5 JP2022509258 A5 JP 2022509258A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated
- dpep
- seq
- group
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024007364A JP2024028553A (ja) | 2018-11-30 | 2024-01-22 | Ｄｐｅｐ－１結合剤および使用の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862773733P | 2018-11-30 | 2018-11-30 | |
| US62/773,733 | 2018-11-30 | ||
| PCT/IB2019/001289 WO2020109864A1 (en) | 2018-11-30 | 2019-12-02 | Dpep-1 binding agents and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024007364A Division JP2024028553A (ja) | 2018-11-30 | 2024-01-22 | Ｄｐｅｐ－１結合剤および使用の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022509258A JP2022509258A (ja) | 2022-01-20 |
| JP2022509258A5 true JP2022509258A5 (enExample) | 2022-10-05 |
| JP7535514B2 JP7535514B2 (ja) | 2024-08-16 |
Family
ID=70853301
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530885A Active JP7535514B2 (ja) | 2018-11-30 | 2019-12-02 | Ｄｐｅｐ－１結合剤および使用の方法 |
| JP2024007364A Pending JP2024028553A (ja) | 2018-11-30 | 2024-01-22 | Ｄｐｅｐ－１結合剤および使用の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024007364A Pending JP2024028553A (ja) | 2018-11-30 | 2024-01-22 | Ｄｐｅｐ－１結合剤および使用の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11286278B2 (enExample) |
| EP (1) | EP3887390A4 (enExample) |
| JP (2) | JP7535514B2 (enExample) |
| AU (1) | AU2019386379B2 (enExample) |
| CA (1) | CA3121300A1 (enExample) |
| IL (1) | IL283231B1 (enExample) |
| WO (1) | WO2020109864A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019386379B2 (en) * | 2018-11-30 | 2025-05-22 | Arch Biopartners, Inc. | DPEP-1 binding agents and methods of use |
| IL307413A (en) * | 2021-04-08 | 2023-12-01 | Nat Res Council Canada | Dpep-1 binding agents and methods of use |
| EP4574146A1 (en) | 2023-12-18 | 2025-06-25 | Telara Pharma S.L. | Dhp-i inhibitors for use as neuroprotectants and in the treatment of neuroinflammatory diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7223558B2 (en) * | 2001-07-11 | 2007-05-29 | Bristol-Myers Squibb Company | Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof |
| US8258256B2 (en) * | 2006-01-05 | 2012-09-04 | The Johns Hopkins University | Compositions and methods for the treatment of cancer |
| EP2561359A1 (en) * | 2010-04-20 | 2013-02-27 | Addex Pharma SA | Chimeric polypeptides useful in proximal and dynamic high-throughput screening methods |
| WO2012112420A1 (en) * | 2011-02-14 | 2012-08-23 | Allergan, Inc. | Treatments using psma ligand endopeptidases |
| WO2015120536A1 (en) | 2014-02-13 | 2015-08-20 | Arch Cancer Therapeutics, Inc. | Peptides that block leukocyte recruitment and methods of use |
| JP7054674B2 (ja) * | 2015-08-11 | 2022-04-14 | アーチ バイオパートナーズ， インコーポレイテッド | Ｄｐｅｐ－１結合組成物および使用の方法 |
| WO2018064602A1 (en) * | 2016-09-30 | 2018-04-05 | Baylor College Of Medicine | Chimeric antigen receptor therapy with reduced cytotoxicity for viral disease |
| EP3519436A4 (en) * | 2016-09-30 | 2020-09-09 | Baylor College of Medicine | TISSUE-ORIENTED ANTIBODY-BASED GENE THERAPY |
| AU2019386379B2 (en) * | 2018-11-30 | 2025-05-22 | Arch Biopartners, Inc. | DPEP-1 binding agents and methods of use |
-
2019
- 2019-12-02 AU AU2019386379A patent/AU2019386379B2/en active Active
- 2019-12-02 WO PCT/IB2019/001289 patent/WO2020109864A1/en not_active Ceased
- 2019-12-02 US US16/700,901 patent/US11286278B2/en active Active
- 2019-12-02 JP JP2021530885A patent/JP7535514B2/ja active Active
- 2019-12-02 EP EP19891278.4A patent/EP3887390A4/en active Pending
- 2019-12-02 CA CA3121300A patent/CA3121300A1/en active Pending
-
2021
- 2021-05-18 IL IL283231A patent/IL283231B1/en unknown
-
2022
- 2022-02-14 US US17/670,998 patent/US20220251140A1/en not_active Abandoned
-
2024
- 2024-01-22 JP JP2024007364A patent/JP2024028553A/ja active Pending
-
2025
- 2025-07-07 US US19/261,807 patent/US20250333443A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025090743A5 (enExample) | ||
| JP2006149365A5 (enExample) | ||
| TWI653980B (zh) | 治療及預防缺血性傷害之組成物與方法 | |
| JP2018171063A5 (enExample) | ||
| EP2594581A3 (en) | Peptide vaccines with Seq Id No: 178, 174, 186 or 194 for cancers expressing tumor-associated antigens | |
| JP2011529084A5 (enExample) | ||
| Ryge et al. | New indolicidin analogues with potent antibacterial activity | |
| NZ591130A (en) | Compositions comprising a PD-1 antagonists and cyclophosphamide and methods of use thereof | |
| Bhattacharjya | NMR structures and interactions of antimicrobial peptides with lipopolysaccharide: Connecting structures to functions | |
| JP2023528207A5 (enExample) | ||
| ATE278708T1 (de) | Conotoxin peptid pviia | |
| JP2020526497A5 (enExample) | ||
| FI4034555T3 (fi) | Dap10/dap12-fuusiopolypeptidit | |
| Ryge et al. | Novel lysine‐peptoid hybrids with antibacterial properties | |
| JP2019038772A5 (enExample) | ||
| Bionda et al. | Solid‐phase synthesis of fusaricidin/li‐f class of cyclic lipopeptides: Guanidinylation of resin‐bound peptidyl amines | |
| US20180201653A1 (en) | Polypeptide compound and preparation method and use thereof | |
| JP2006503088A5 (enExample) | ||
| RU2017104284A (ru) | Выделенные полипептиды cd44 и их применение | |
| KR20180086277A (ko) | 폴리펩티드 화합물, 그리고 이의 제조 방법 및 적용 | |
| JP2017508734A5 (enExample) | ||
| WO2020093055A3 (en) | Peptide libraries with non-canonical amino acids | |
| RU2011130796A (ru) | Пептиды c1orf59 и содержащие их вакцины | |
| CN105837675A (zh) | 一组阳离子抗菌肽及其制备方法 | |
| EP1842911A4 (en) | HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS |